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Abstract
The formation of synapses, the specialized points of chemical communication between neurons, is a highly regulated
developmental process fundamental to establishing normal brain circuitry. Perturbations of synapse formation and function
causally contribute to human developmental and degenerative neuropsychiatric disorders, such as Alzheimer’s disease,
intellectual disability, and autism spectrum disorders. Many genes controlling synaptogenesis have been identified, but lack
of facile experimental systems has made systematic discovery of regulators of synaptogenesis challenging. Thus, we created
a high-throughput platform to study excitatory and inhibitory synapse development in primary neuronal cultures and used
a lentiviral RNA interference library to identify novel regulators of synapse formation. This methodology is broadly
applicable for high-throughput screening of genes and drugs that may rescue or improve synaptic dysfunction associated
with cognitive function and neurological disorders.
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Introduction
The synapse is the subcellular locus of neuronal communication
in the central and peripheral nervous system[1]. Many neurode-
velopmental and neurodegenerative disorders are hypothesized as
diseases of synapse formation or communication. Genes encoding
proteins involved in synapse formation and regulation are often
mutated in monogenetic autism spectrum disorders and intellec-
tual disabilities[2–4].
The complexity of the organization, formation and regulation of
the synapse, built of a large and diverse number of scaffold
proteins, trans-synaptic adhesion molecules, neurotransmitter
transporters, signaling molecules and cytoskeletal proteins[1]
necessitates automated high throughput screening methodology
to systematically identify the numerous factors controlling synapse
structure and function. Traditional single gene studies, although
highly successful, cannot fully capitalize on the wealth of
proteomic and genomic data now available for the brain. Forward
genetic, mainly non-quantitative, screens in fly and worm
demonstrate the feasibility and value of such a screening approach,
but invertebrate neural systems do not capture all the neural
functions associated with cognition and disease in higher order
organisms.
Here we present an automated high-throughput screening
method of mouse primary cortical neurons coupled with a novel
multiplexed image analysis algorithm for unbiased, unsupervised
analysis of synapse development. We used this platform for a
systematic loss-of-function genomic screen in 96-well microplate
format targeting over a hundred endogenous expressed genes
using lentiviral delivery of short hairpin RNAs (shRNAs), which
permits expression of the RNAi reagent in all neurons in the well.
We validate the approach by identifying previously established
regulators of synapse function, and extend our understanding of
synapse formation by identification of novel regulators. The
methodology and image analysis algorithm presented are valuable
tools for high-throughput genomic and drug screening approaches
that aim to identify genes and drugs that regulate or restore (e.g. in
disease models) synapse development of rodent or human
embryonic stem cell (ESC) or induced pluripotent stem cell (iPSC)
derived neurons.
Methods
Content of the shRNA lentiviral library
A pLKO.1 based lentiviral library consisting of 597 unique
21 mer shRNA sequences driven by a U6 promoter[5] was
designed to suppress the expression of 118 endogenous mouse
genes: 10 adenylate cyclases, 16 phosphodiesterases, 25 dual
specificity protein phosphatases, 41 genes involved in G-protein
signaling (9 G-protein coupled receptors, 6 G-protein-coupled
receptor kinases, 23 regulators of G-protein signaling (RGS
family), one scaffold protein, one protein kinase and one gene
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(LOC100047944) since retracted from Pubmed) and 23 glutamate
receptors. One hundred and fifteen genes were targeted by five
unique hairpin sequences (four hairpins targeting the coding
sequence (CDS), one the 39 untranslated region (UTR)) and three
genes by 4 unique hairpins (three targeting the CDS, one the
39UTR). We included five unique positive control hairpins
targeting the positive control genes Psd95, Synapsin-1, Tsc1,
Gephyrin and Pten that are known to be critical for synapse
development. We included on each plate unique shRNA negative
control sequences targeting GFP, RFP, and luciferase. A GFP
expressing vector controlled both virus production by HEK293
cells and infection of primary neurons. The lentiviral vector
contains a Pgk1 promoter driven PAC (puromycin N- acetyl-
transferase) gene to select infected neurons by conferring resistance
to the selection drug and ribosomal inhibitor puromycin, an
aminonucleoside antibiotic from Streptomyces alboniger. Table S1
presents target sequences of all shRNA reagents tested.
The library consisted of seven 96-well plates, each plate
containing approximately 85 spatially randomly distributed
shRNAs targeting the mouse genes. All five hairpins targeting
the same gene were located on the same 96-well plate. Each plate
also contained five different negative (non-targeting) control
shRNA lentiviruses that target GFP, RFP, b-galactosidase or
luciferase, 2 GFP expressing viruses (as a control for virus
production) and 4 empty wells (to confirm puromycin selection).
An eighth 96-well negative control plate was built of 80 unique
control shRNA expressing lentiviruses targeting GFP, RFP, b-
galactosidase and luciferase to create a control null distribution to
benchmark the effects of the shRNAs targeting the mouse genes in
the screen.
High-throughput production of shRNA lentiviral library
A third generation lentiviral vector system consisting of three
different plasmids encoding (1) gag, pol and rev, (2) VSV-G
envelope, (3) pLKO.1-shRNA vector was transiently transfected
into HEK293 cells in 96-well plates to produce virus in high-
throughput. The lentiviral supernatant consisting of 10% serum
and 10% albumin in DMEM medium was quality control checked
in Alamar Blue survival A549 cell survival assays for appropriate
high (.5E7) titer relative to a standard pLKO.1 reference virus.
The limited variability (within a 2 fold-range) of titer across the
library was instrumental in obtaining uniform infection conditions
across all shRNAs of the library[5] and reproducible perturbations
of synapse and dendrite development.
High-throughput culture of mouse embryonic cortical
neurons
Neuronal cultures were prepared by enzymatic (0.01% DNAse
(Cat# DN25, Sigma), 10 unit per mL of Papain (Cat# LS 00319,
Worthington) digestion of cortices harvested from mouse embryos
(embryonic day 18, C57Bl/6 mice) following standard procedures.
Neurons were seeded robotically in 100 or 200 ml neurobasal
medium containing 2% B27, 1% penicillin/streptopmyces and
2 mM Glutamax (all from Invitrogen) at a density of 15,000 or
20,000 neurons per well (depending on the experiment) in 96-well
microtiter plates (black wall, clear bottom; BD Falcon) coated with
poly-D-lysine (Sigma). They were grown at 37uC and 5% CO2 in
a humidified atmosphere. On day-in- vitro (DIV) 4 or 5 the
neurons were infected with the shRNA lentiviral library that
ranged between 3 and 10 ml virus, depending on the titer of the
library. On DIV6 they were exposed to puromycin (final
concentration of 0.2 mg/ml. Cat# P9620, Sigma) to select infected
cells, and fixed on DIV14 with a solution of 4% paraformalde-
hyde, 4% sucrose in phosphate buffered saline (PBS). All liquid
handling steps including infection (below) were performed with a
JANUS (Perkin Elmer) liquid handling robot.
High throughput viral infection optimization
Infection conditions were optimized by exposing after 4 days in
vitro culture (DIV4) primary cortical neurons in 96-well plates to
293T cell supernatant containing virus and subjecting on DIV6
cells to puromycin selection or control medium as described
above. We tested a wide (0–15 ml) range of empty vector pLKO.1
control to identify optimal infection conditions in mouse primary
neurons, and used these conditions to test the shRNA expressing
lentiviral library in a more narrow range (3–7 ml). On DIV14,
neurons were fixed and processed for immunofluorescence using
antibodies that recognize the neuronal marker NeuN (Cat#
MAB377, mouse, Millipore) and secondary donkey anti-mouse-
Alexa488 antibodies (Cat# A21202, Invitrogen) (see below). The
number of NeuN positive cells in each well was counted using an
Acumen LaserScan (TTP labtech). The neurons were also stained
with the dendrite marker MAP2 (NB300-213, chicken, Millipore
using a secondary donkey-anti-Chicken-DyLight647 antibody
from Jackson Laboratories; Cat# 703-495-155) and imaged on
an IXM high content microscope (Molecular Devices) using a 4X
objective (4X S Fluor, 0.2 N.A, Nikon) for gross inspection of
health. This experiment narrowed down the range of library virus
tested (between 3 and 10 ml) prior to the actual synapse screen to
identify the optimal viral library dose. The infection efficiency of
each individual shRNA was expressed as percentage of Hoechst
positive cells in the presence and absence of puromycin
determined by an Acumen LaserScan (TTP labtech). The primary
screen was done in two batches of four unique 96-well virus plates
that were each infected in three to five replicates. The infection
efficiency of each individual shRNA was confirmed in line for all 8
virus 96-well plates (mean infectivity across all shRNAs of 1016
19%).
High throughput lentiviral screen of synapse
development
The effect of RNAi mediated suppression of expression of the
target genes was assessed on DIV14. First, neurons were fixed at
room temperature for 15 min with 4% paraformaldehyde and 4%
sucrose in phosphate buffered saline (PBS). They were washed
twice with PBS, permeabilized for 10 min at room temperature
with 0.25% Triton-X100 in PBS, washed twice with PBS and then
blocked for 1 h at 37uC with 5% bovine serum albumin (BSA) in
PBS. Primary antibody staining was performed overnight at 4uC
in the same buffer containing antibodies that recognized PSD95
(Cat# MAB1596. mouse IgG2a, Millipore), Synapsin-1 (Cat#
AB1543, rabbit, Millipore), Gephyrin (Cat# 147 011, mouse
IgG1, Synaptic Systems) and Map2 (NB300-213, chicken,
Millipore). The next day they were washed five times with PBS,
incubated for 1 h at room temperature with fluorescently labeled
secondary antibodies (Cat# A21135, donkey anti-mouse-IgG2a-
Alexa594 Cat# A21206, donkey-anti-Rabbit-Alexa488; Cat#
A2140, Adonkey anti-mouse-IgG1a-Alexa 674 [all from Invitro-
gen]) and donkey-anti-Chicken-AMCA (Cat# 103-155-155,
amino-methyl-coumarin-acetate; Jackson Laboratories), and then
washed 5 times with PBS. All washing steps were performed with a
robotically operated ELK405 micro platewasher (Biotek). The 96-
well plates were processed with a robotically operated automated
IXM imaging microscope (Molecular Devices) and a 40X
objective (40X S ELWD, 0.6 N.A, Nikon). Nine or 12 fields were
imaged per well.
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High-throughput image analysis algorithm for synapse
development
A synapse development algorithm was developed that tracked
21 parameters by high-content imaging: number, synapse area,
synapse eccentricity, synaptic protein expression levels and density
of Psd95, Syn1 and Gphn punctae; number and density of
excitatory Psd95-Syn1 and inhibitory Gphn-Syn1 punctae.
Dendrite length was tracked to identify images with low dendritic
outgrowth and to calculate synaptic densities by dividing the
number of punctate per unit MAP2 length.
Image analysis was performed using the open-source CellPro-
filer software[6]. A serial set of image analysis algorithms (an
‘image analysis pipeline’) was constructed to measure features in
each of the Gephyrin, Synapsin-1, PSD-95, and MAP2 channels.
Each of nine or twelve sites per well was analyzed independently,
and the image processing was parallelized by sending batches of
images to the Broad Institute’s computing cluster. The analyzed
data was merged and stored (http://www.cellprofiler.org, Broad
Institute) in a MySQL (Oracle, Inc.) database.
The CellProfiler pipeline will be included in Supplementary
Materials with further details and made freely available online
(http://www.cellprofiler.org/published_pipelines.shtml) but is
briefly outlined here. First, an illumination correction function
was calculated for each channel to correct for persistent
illumination variations across each 96-well plate (due to many
possible sources, including optical hardware irregularities, illumi-
nation patterns, or shading). Illumination functions were created
by averaging all the images of each channel across each plate, then
smoothing the resulting image with a large median filter (1006100
pixels), and finally saved offline. Each site was then processed in a
separate processing pipeline as follows. The four channels’ raw
images were divided by their respective plate/channel illumination
function. Next, translational misalignments were corrected by
maximizing the mutual information of the PSD-95 and Gephyrin
channels relative to the Synapsin-1 channel. The three synapse
channels were enhanced using a top-hat morphological filter with
a disk structuring element from 6–8 pixels in diameter. The MAP2
dendrite channel was enhanced using an ImageJ plugin[7]
executed within CellProfiler called Tubeness[8] http://www.
longair.net/edinburgh/imagej/tubeness/). Summed dendritic ar-
bor lengths per image were measured by image segmentation[9]
and morphological skeletonization with despurring. Synaptic
objects were segmented and low intensity objects were filtered
based on thresholds determined empirically for each experimental
batch. Overlap of each synaptic object pair was measured as pixel
area overlap as well as a simple count of objects with any regional
overlap. Synaptic densities were also calculated (number of
synapses per mm MAP2 length). The effect of shRNAs on
synaptogenesis and dendrite development was assessed by first
aggregating the data of images taken within the same well and
then over replicate wells.
shRNA knockdown validation by western blot
Neuronal cultures were prepared from cortices that were
harvested from mouse embryos (embryonic day 18, C57Bl/6
mice), seeded in 12well poly-D-lysine coated plates (BD Falcon) at
a density of 400,000 cells/well and cultured as described for 96-
well format. On DIV4, half the medium was removed and
conserved. In contrast to 96w- plate infections, optimal infection of
these larger scale neuronal cultures required application of the
cationic peptide protamine sulfate (6 mg/ml, MP Biomedicals),
which neutralizes the charge repulsion between the lentiviral
virions and sialic acid residues on the cellular surface and
centrifugation at room temperature for 30 min, 2200 g. The cells
were placed in the tissue culture incubator for 3–5 hr (37uC, 5%
CO2 in a humidified atmosphere), after which the protamine
sulfate containing supernatant was removed and replaced with the
conserved medium. Neuronal cultures were placed back in to the
tissue culture incubator and subjected to puromycin selection on
DIV6. On DIV14 the culture medium was removed and cell
lysates prepared and analyzed by SDS-PAGE and western blotting
using anti-Axin1 (A0481; Sigma-Aldrich) and anti-Grin2C
(NB300-107; Novus) antibodies. Expression levels relative to B-
actin were determined by measuring the intensity of relevant
bands on scanned western blot quantified using LabWorks
software (UVP). As control we used a pool of 10 negative control
shRNA viruses identified from the negative control plate that had
shown to be innocuous in our synapse assay and 293T cell lysates
expressing human Axin1 and Grin2C constructs.
In utero DNA electroporation
All the procedures for animal surgery and maintenance were
performed following animal protocols approved by the Harvard
Standing Committee on Animal Care and National Institutes of
Health guidelines. To target neocortical layer 2/3 pyramidal
neurons, E15.5 timed-pregnant female C57BL/6 mice (Charles
River, Massachusetts, United States) were anesthetized by 2%
isoflurane. Uterine horns were carefully exposed and 1,2 ml of
DNA at the concentration of 1 mg/ml was injected into the lateral
ventricle of the left hemisphere of intrauterine embryos using a
,30–50-mm-diameter pipette sharply beveled at 15u–20u (Nar-
ishige, Japan), visually confirming the proper site of correct
injection by mixing 0.005% fast green mixed with the DNA. We
used the same shRNA pLKO.1 vector that was used to create
lentivirus that was used for all other assays and an eGFP-N1
expressing vector (Clontech) as negative control. After injection,
the embryo head was held between the paddles of a forcep-type
platinum electrode (0.5 mm diameter) and electric pulses were
delivered five times per second (50 V, 50 ms) (CUY21 electro-
porator, NEPA GENE, Japan). Warm PBS was dropped onto
embryos periodically to prevent drying. The uterus was placed
back into the pregnant mouse, and the anterior muscle and the
skin were sutured separately. Pups were housed with the dam until
they were needed.
Spine imaging in acute brain slices
C57BL/6 mice (16–19 days old) were deeply anesthetized with
isoflurane and decapitated. The brain was rapidly removed and
placed in chilled choline-based cutting solution containing (in mM)
25 NaHCO3, 1.25 NaH2PO4, 2.5 KCl, 7 MgCl2, 25 glucose, 1
CaCl2, 110 choline chloride, 11.6 ascorbic acid, and 3.1 pyruvic
acid. Coronal sections of the brain were cut at 300 mm thickness
using a Leica VT1000S vibratome (Leica Instruments, Nussloch,
Germany) in cold cutting solution. Slices were transferred to ACSF
containing (in mM) 127 NaCl, 2.5 KCl, 25 NaHCO3, 1.25
NaH2PO4, 2 CaCl2, 1 MgCl2, and 25 glucose. Both cutting and
ACSF solution were saturated with 95% O2 and 5% CO2
(pH 7.4). GFP expressing Layer 2/3 pyramidal neurons were
located in acute brain slices under wide field epifluorescence.
Subsequently Z-stacks (1 micron inter-slice spacing) of apical
dendrites were acquired as described previously using 2-photon
laser scanning microscopy and analyzed using custom soft-
ware[10]. For each image stack, the number of spines was
counted and the total dendrite length measured to calculate the
spine density. In addition, the length of each spine was measured
to produce cumulative distributions of this parameter for neurons
of each genotype.
High-Throughput RNAi Screen of Synaptogenesis
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Statistical analysis
Two-tailed t-test and one way analysis of variance (one way
ANOVA) statistical analysis were performed using GraphPad
Prism version 6.
Ethics Statement
Animals were handled according to protocols approved by the
Harvard Standing Committee on Animal Care, in accordance
with NIH guidelines (Protocol number 03551).
Results
Functional analysis of synaptogenesis of primary neurons
requires consistency of culture conditions, uniform genetic and
chemical perturbations or unsupervised automated analysis
methodology. Here we describe the development and implemen-
tation of lentiviral high throughput RNAi screening methodology
and quantitative image analysis algorithms for robust interrogation
of the regulatory function of genes in excitatory and inhibitory
synaptogenesis of mouse primary cortical neurons (Fig. S1).
Design of an automated synapse development imaging
algorithm
We used the freely available CellProfiler software[6] to develop
an automated image analysis pipeline of synaptogenesis. It takes
advantage of multiple fluorescence channels and high information
content available in images acquired with fluorescence light
microscopy. A critical feature of this imaging algorithm is the
ability to selectively parse molecular aspects underlying synapse
development: (1) synapse morphology (synapse area, eccentricity),
(2) synaptic protein expression levels (measured as fluorescence
intensity normalized to the area of each individual synapse), (3) the
number and density (relative to density length) of individual
synaptic punctae in the culture, (4) the molecular composition of
the synapse by simultaneously marking different synaptic proteins
with different antibodies in a multiplex immunostaining protocol
and (5) dendrite outgrowth to calculate synaptic density and
determine gross changes in neural development upon RNAi
perturbations.
High-throughput synapse screen
We applied the image algorithm to examine by RNAi the
regulatory role of genes in the development of (overlapping) pre-
synaptic and post-synaptic boutons of excitatory and inhibitory
synapses, visualized with antibodies recognizing Synapsin-1 (Syn1;
general pre-synaptic marker), Psd95 (excitatory postsynaptic
marker) and Gephyrin (Gphn; inhibitory postsynaptic marker).
Excitatory and inhibitory synapses were defined by the presences
of overlapping Psd95-Syn1 and Gphn-Syn1 punctae (Fig. S2, S3,
S4).
We identified conditions in which 100% of embryonic day 18
cortical neurons cells are lentivirally infected and perturbed by
RNA interference treatment without evidence of cell loss (Fig. 1).
This protocol was employed to screen in 96-well plate format (Fig.
S1) an RNAi library consisting of 607 individual shRNA sequences
targeting mouse genes, some with suspected functions in synapse
development (Table S1). Hairpins (shGFP, shRFP, shb-galactosi-
dase, shLuciferase) that target proteins not expressed in neurons
were used as negative controls.
Positive control shRNAs targeting mRNAs encoded by Gphn,
Syn1, Psd95 and Tuberous scleroris-1 (Tsc1) included in the screen
validated the synapse algorithm. They quantitatively reduced, as
expected, the number, density and synaptic expression of their
intended Gphn, Syn1 and Psd95 targets (Fig. 2B,C), Fig. S5,
statistical analysis in Tables S2 (2-tailed t-test) and S3 (one way
analysis of variance (one way ANOVA)), confirming the clear
qualitative visual impression of decreased punctae number and
Psd95 and Gphn synaptic protein expression levels (Fig. 2A, Fig.
S2, S3, S4). They also lowered the density of excitatory and
inhibitory synapses, defined by the algorithm as overlapping Psd95
and Synapsin-1 punctae or Gphn and Syn1 punctae, respectively
(Fig. 2D, Fig. S5E-F). Strong hairpins also reduced punctae
development of the opposite class (e.g. shPSD95 reduces Gphn
and Syn1 development), which might be attributable to off-target
effects or secondary homeostatic effects induced by changes in
network activity.
The optimal infection efficiency (mean infectivity of 101%6
19%) of all 607 shRNAs tested and the little variation in replicate
measurements of 21 synapse and dendrite parameters across
replicate shRNA perturbations within the primary screen (median
%CV of , 7%) and between the primary screen and two
independent secondary screens (7% , median %CV , 25%) (Fig.
S6) demonstrated the reproducibility and robustness of the RNAi
screening and imaging methodology.
The automated image analysis platform makes possible analyses
of individual shRNAs and the population of RNAis in the library
to discern effects on specific neuronal phenotypes across 33,400
acquired images. For instance, we observed enrichment of mouse
genes reducing dendrite development compared to the control
negative hairpin population (Fig. S7; p = 0.0348, 2-tailed t-test).
Importantly, the absence of correlation between synapse develop-
ment and dendrite outgrowth (Fig. S8) indicates that differences in
synapse density were not caused by changes in gross development.
The similar distributions of shRNAs targeting mouse genes and
the negative controls (Fig. S9) suggest that the majority of shRNAs
do not regulate excitatory (p = 0.6944, 2-tailed t-test) or inhibitory
synapse development (p = 0.2515, 2-tailed t-test). Furthermore,
linear regression analysis indicates a high degree of correlation
between the development of post-synaptic excitatory Psd95 and
pre-synaptic Syn1 punctae (Fig 3A), between post-synaptic
inhibitory Gphn and pre-synaptic Syn1 punctae (Fig 3B) and
between excitatory and inhibitory synapses (Fig. 3C, D). Noted
exceptions are positive control hairpins with moderate knockdown
effect on Psd95 and Gphn expression that specifically affected
excitatory or inhibitory neurons respectively (Fig. 2, 3, Table S2
and S3). This is further highlighted by cumulative frequency
distributions of the effect of shPsd95, shGphn, shSyn1 and shTsc1
on excitatory and inhibitory synapse development relative to
negative controls and the mouse library (Fig. S9). This demon-
strates that the image analysis algorithm permits unbiased analysis
of a large number of perturbations on several complex phenotypic
aspects of synaptogenesis.
Identification of novel regulators of synapse
development
We applied the image analysis algorithm to identify novel
regulators of synapse development in the RNAi screen that
targeted 118 genes. The path of RNAi-to-gene validation we
describe aimed to maximize discovery of on target hits by
prioritizing potential hit genes by (1) the size-effect on synapse
density (reduction of synaptogenesis by§40%), (2) the number of
shRNA sequences that produce the same phenotype (2 of 5
shRNA reducing synaptogenesis by §40%) (3) reproducibility
(shRNA effect repeated in 3 independent screens with minimal
variability) and (4) visual confirmation of the phenotype of the
candidate genes accordingly highlighted by the imaging algorithm.
This nominated Axin1 and Grin2C as potential novel regulators of
synaptogenesis, visually (Fig 4A and Fig. S2, S3, S4) and
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quantitatively (Fig 3, 4B,C and Fig S10 A–C and S11 A–C). This
does not exclude the possibility that single shRNA hits (e.g. Axin2
(Fig. S12) or multiple hairpin hits with weak effects may also
nominate potential regulators of synapse development (e.g. Tsc1,
Fig. 2 and Fig. S5).
ShRNA-mediated suppression of Grin2C equally impinges on
the formation of all classes of synaptic boutons (one way ANOVA,
Table S3). However, Axin1 preferentially regulates the develop-
ment of excitatory post-synaptic Psd95 and Psd95-Syn1 punctae,
with only modest or little effect on Gphn and Syn1 punctae
development (one way ANOVA, Table S3).
Importantly, the on-target specificity of RNAi reagents was
confirmed by shRNA mediated protein knockdown of Axin1 and
Grin2C, which correlated with the defective synapse phenotype
(Fig. 4D, Fig. S10D, S11D). Finally, the synapse reducing effect of
positive control shPsd95 and shTsc1 (Fig. S13) and shAxin1 and
shGrin2C (Fig. 4E) was confirmed in orthologous spine assays in
acute brain slices. The discovery of novel candidate positive
regulators of synaptogenesis with general – Grin2C- or specific
effects on excitatory synaptogenesis – Axin1 - is a further
demonstration of the utility of the functional genomic screening
methodology and the synapse imaging algorithm.
Discussion
The high-throughput screening methodology presented here
enables robust and reproducible unbiased interrogation of the
molecular pathways underlying synapse development in primary
culture of mouse neurons. This provides a valuable system for the
study of normal developmental and activity dependent synapse
formation as well as perturbations resulting from disease-associ-
ated gene mutations. We present protocols to achieve neuronal
lentiviral infection rates of near 100% and little variation among
replicate RNAi perturbations, an indication that scale up for
genome-wide functional screens and large-scale drug screens of
synaptogenesis is feasible.
Previous successful efforts towards screening of genes that
regulate synapse formation have relied on heterologous sys-
tems[11], low-efficiency lipid-based transfections of siRNAs that
require visual identification of the affected neurons and manual
analysis of synapse number[12], or indirect measures of synapse
formation such as fluorescence intensity rather than identification
of individual synaptic punctae[13]. By contrast, to our knowledge,
this is the first example of a quantitative automated screen for
endogenous synapse development in primary neuronal cultures
using unbiased and unsupervised image analysis.
Rich information can be harvested from this assay using the
quantitative automated image analysis algorithm presented here,
which is freely available and built on open-source software. The
discovery of genes regulating the development of specific (e.g. pre
v.s post) synaptic compartments is one important example of the
power of the RNAi and image analysis methodology presented.
This tool can parse several aspects of synapse development,
including synapse size, synaptic protein expression levels and
composition of synapses, as well as dendrite outgrowth. In the
RNAi screen we identify 2 novel regulators of synapse develop-
ment, Axin1 and Grin2C. These genes are components of
pathways that are known modulators of the biology of synapses:
Wnt pathway for Axin1 and NMDA receptors for Grin2C[14–16].
The lack of direct interaction that has previously been observed
between Grin2C and PSD95 PDZ domains[17] may be offered as
one explanation for defects in synaptogenesis. In addition, since
Grin2C is expressed early postnatally and NMDA receptors
containing this subunit display less voltage-dependent block by
extracellular magnesium, Grin2C may play a privileged role in
early synaptogenesis[18,19]. Ostensibly, the scaffold protein Axin
is localized at PSD95 enriched post-synaptic density fractions[15]
and may regulate several key protein complexes that govern
synaptogenesis, spine morphogenesis and synaptic function.
Examples of these complexes include Gsk3B/APC/B-catenin, B-
catenin/Cadherin, S-SCAM/Stargazin/AMPA-R/Gsk3B/Bcate-
nin, Grb4/Ephrin-B/GIT1/Actin, and Cdk5[14,20–23]. Com-
peting for Axin1 availability under conditions of partial loss of
expression, dysregulation of all these complexes may underlie
impaired synapse formation. Additional experiments are needed to
begin to elucidate the mechanisms by which Grin2C and Axin1
may regulate synaptogenesis.
A crucial feature of the image analysis algorithm is the ability to
separately analyze punctae of different classes, which can be used
to study the intramolecular composition of synaptic compart-
Figure 1. Lentiviral infection optimization of mouse primary cortical cultures in 96- well plate format. (A) Embryonic age 18 cortical
neurons were seeded in 96-well plates (DIV0) and mock infected or infected with pLKO.1 empty vector lentivirus (DIV4), subjected to control medium
(A,C) or puromycin containing selection medium (DIV6), fixed and processed for immunostaining for NeuN (in red) and Map2 expression (in green)
(DIV14). (B) The infection efficiency was assessed by counting the number of NeuN positive neurons in the absence and presence of puromycin using
laserscan cytometry.
doi:10.1371/journal.pone.0091744.g001
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Figure 2. Automated image analysis algorithm quantifies changes in synapses development. (A) Relative to the negative control hairpin
(shLacZ #30 targeting B-galactosidase) individual hairpin sequences targeting Psd95 (two unique sequences), Gphn, Syn1 and Tsc1 show the
expected decrease in development of Psd95, Gphn and Syn1 punctae respectively. Scale bar represents 10 mm. Image results were quantified using
High-Throughput RNAi Screen of Synaptogenesis
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ments. These punctae can be visualized with multiplexed
antibodies (or proteins fused with fluorescent proteins) labeled
with fluorophores with different spectra. Here we used the
algorithm for functional genomic analysis of the development of
pre- and post-synaptic terminals and of excitatory and inhibitory
synapses. A direct disease relevance to the study of these particular
classes of synapses is the emerging view that certain autism
spectrum disorders (ASDs) and schizophrenia may be caused by
an imbalance in the development and/or activity of excitatory and
inhibitory synapses[24]. Moreover, de novo CNV analyses
indicate an enrichment of genes of the PSD95 complex in
schizophrenia[25], and rare exonic deletions implicate Gephyrin
as a risk factor for autism, schizophrenia and seizures[26]. The
recent discovery of de novo CNV deletions of Axin1[27] and
exome variants of the Grin2C family member Grin2B associated
with ASDs[27] further exemplify the utility of the synapse analysis
the synapse imaging algorithm, showing the effect on (B) dendrite outgrowth and density of individual synaptic punctae and (C) Psd95, Gphn and
Syn1 protein expression in the synaptic punctae (per synapse median fluorescence intensity normalized to the area). (D) shRNA targeting Psd95 and
Syn1 and shRNA targeting Gphn and Syn1 also reduce excitatory and inhibitory synapse development, respectively. The data in (B) and (D) represent
the median and median absolute deviations of the primary screen and 2 independent secondary experiments * p,0.05 or less (2-tailed T-test)
compared to respective negative control shRNA. The data in (C) present the mean and standard deviation of the primary screen. The quantitative
results and full statistical analysis of all 5 shRNAs targeting each gene is presented in Fig. S5 and Tables S2 and S3.
doi:10.1371/journal.pone.0091744.g002
Figure 3. Primary screen analysis of the effect of shRNAs on synapse development. The effect of 607 unique shRNAs targeting mouse
genes and of the negative control hairpins correlated well between (A) post-synaptic Psd95 and pre-synaptic Syn1 punctae (r2 of 0.47 for mouse RNAi
and 0.59 for negative control shRNA population), (B) between inhibitory post-synaptic Gphn and pre-synaptic Syn1 punctae (r2 of 0.43 for mouse
RNAi and 0.69 for negative control shRNA) and between (C) excitatory (Psd95-Syn1) and inhibitory synapse (Gphn-Syn1) density development (r2 of
0.73 for mouse genes and 0.76 for negative control). shPsd95 specifically reduces excitatory synapse density, shGphn reduces inhibitory synapse
density and shSyn affects both. The 2 novel regulators of synapse development identified in this screen are Axin1 and Grin2C (see also Fig. 4). (D)
Regression analysis of excitatory-inhibitory synapse development presented in (C) highlights the specificity of shPsd95 and shGphn for excitatory and
inhibitory synapse development. The quantitative results and statistical analysis of all 5 shRNAs targeting each gene is presented in Fig. S5, S10 and
S11 and Table S2 and S3.
doi:10.1371/journal.pone.0091744.g003
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Figure 4. Identification of novel regulators of synapse development in the RNAi screen. (A) Representative selected areas of
immunofluorescence images taken with a 40X objective of dendrites and synapses of negative control (shNegCtrl; shLacZ#30) and the most effective
shRNAs targeting Axin1 and Grin2C, and the quantification thereof (B) (median and median absolute deviations of primary screen and two
independent secondary tests). Asterisks denote p,0.05 or less (2-tailed t-test). The scale bar represents 10 mm. (C) shRNAs also reduce synaptic
expression levels of Psd95 and Gphn. (D) Confirmation of the on-target knockdown of shAxin1 and shGrin2C by western blot. (E) Orthologous spine
density assays experiments visually and quantitatively confirm that shRNA to Axin1 and Grin2C reduced spine density. p,0.0001 (2-tailed T-test). Fig.
S10 and S11 and Tables S2 and S3 present data of all 5 shRNAs targeting these genes.
doi:10.1371/journal.pone.0091744.g004
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pipeline in the functional analysis of risk genes of neurological
disorders. Indeed, the RNAi screening and synapse quantitation
methodology will be invaluable tools for the translation of genetic
associations of human neurological disorders identified in genome
wide association and exome sequencing studies (e.g. candidate risk
genes of Alzheimer’s disease, schizophrenia and autism spectrum
disorders[28,29]) into pathophysiological mechanisms.
Our RNAi screening protocols and secondary assay validation
strategy should be amenable to the analysis of other neural cell
types and phenotypes including developmental assays (e.g. axo-
dendritic development), electrophysiological read-outs (e.g. 96-well
microelectrode array set-up) and synaptic activity[30]. The
imaging algorithm may be used for both in-vitro and in-vivo
synaptic punctae analysis. Potential applications of our system
include screening for drugs and genes that regulate or rescue
synaptic disorders underlying Alzheimer’s disease, autism spec-
trum disorders (e.g. syndromes of Fragile X, Tuberosclerosis, Rett
and Angelman) and neuropsychiatric disorders (e.g. monogenetic
DISC1 disorders, 22q11 syndrome).
Supporting Information
Figure S1 Overview of the high-throughput screening
methodology of synaptogenesis. This includes seeding and
lentiviral infection of mouse primary neurons in 96-well format,
selection of infected cells with puromycin, immunofluorescence
staining and automated high content image analysis of synapses
and dendrites. Quality control measurements confirmed infection
efficiency, the effect of positive control shRNA on synapse
development and absence of toxic effects. Genes were pursued
in secondary experiments if 2 or more shRNAs in the primary
screen reduced synapse development by 60% or more. Secondary
experiments included retesting twice all 5 shRNAs targeting each
gene in the identical synapse development screen, spine develop-
ment assays in slice cultures and on-target knockdown confirma-
tion by western blots.
(TIF)
Figure S2 Pipeline of the synapse development algo-
rithm. Critical steps of the algorithm are displayed using a
fluorescence image from a negative control shRNA LacZ#30 as
an example. (A) Whole field fluorescence images of dendrite (A1–
F1), Psd95 (A2–E2), Gphn (A3–E3) and Syn1 (A4–E4) were
acquired with a high-throughput microscope using a 40X
objective. Scale bar denotes 25 mm. Successive image processing
steps include a background illumination correction (B1–B4), the
results of which are showed in C1–C4, followed by image
thresholding (D1–D4), object segmentation (E1–E4), skeletoniza-
tion of the dendrites (F) and identification of overlapping Psd95-
Syn1 and Gphn-Syn1 synaptic punctae pairs shown superimposed
on the dendrite mask (G). This was instrumental in calculating
synapse area, synaptic protein expression and density of synapse
(pairs) and the dendrite length per image. Data is aggregated
across all images of each individual well and then of replicate wells
of the same shRNA sequences to obtain the median, median
absolute deviation and % coefficient of variation.
(TIF)
Figure S3 Microscopy analysis of shRNA induced
changes in synapse development. Whole field images taken
with a 40X objective of representative wells infected with
lentiviruses encoding negative, positive control shRNA and two
novel synapse regulators. Relative to the negative control hairpin
LacZ#30 (A1–A4), unique individual hairpin sequences targeting
Psd95 (B1–B4, C1–C4), Gphn (D1–D4), Syn1 (E1–E4) show the
expected decrease in development of Psd95, Gphn and Syn1
punctae respectively. RNAi of Tsc1 (F1–F4) reduced post-synaptic
Psd95 and Gphn punctae and pre-synaptic Syn1 punctae. (G1–
G4) and (H1–H4) display the effect of shRNA targeting the novel
synapse regulators Axin1 (G) and Grin2C (H). Scale bar denotes
25 mm. Fig. 2 and 4 presents magnifications of representative
selected areas of each of these images.
(TIF)
Figure S4 Segmentation masks of RNAi induced chang-
es in synapse development identified by the synapse
imaging algorithm. Segmentation masks of images presented in
Fig. S3 demonstrate that the algorithm is able to successfully identify
changes in Psd95 (A2–H2), Gphn (A3–H3), Syn1 (A4–H4) and
overlapping Psd95-Syn1 and Gphn-Syn1 punctae (A5–H5) induced
by shPsd95 (B1–B5), shGphn (C1–C5), shSyn1 (D1–D5), shTsc1
(E1–E5), shAxin1 (F1–F5) and shGrin2C (G1–G5) in comparison to
the negative control (A1–A5). Scale bar denotes 25 mm.
(TIF)
Figure S5 Quantification of RNAi induced changes in
synapse development measured by automated image
analysis. The effects (median and median absolute deviations) on
dendrite outgrowth (A), synapse development (B–F) and synaptic
protein expression (mean and SD of primary screen results only)
(G–I) of all 5 shRNA targeting Psd95, Gphn, Synapsin1 and Tsc1
was quantified using the synapse development algorithm. Data
presented is the average of the primary screen and 2 independent
secondary experiments. *p-values,0.05 or less (2-tailed t-tests, see
table S2). This figure highlights the specificity of shPsd95, shGphn
and shSyn1 on the development of (B) Psd95, (C) Gphn and (D)
Syn1 punctae respectively.
(TIF)
Figure S6 Frequency distribution of % coefficient of
variation of the effect of shRNAs on synapse and
dendrite development in the primary screen. The
averages and %CV was calculated in the primary screen for
replicates of each of the 597 mouse and 80 negative control
shRNAs (3–5 replicates per shRNA) in the library. Frequency
distribution histograms of %CV of (A) number and (B) density of
synaptic punctae, (C) number and (D) density of excitatory Psd95-
Syn1 and Gphn-Syn1 punctea and (E) dendrite length demon-
strate the robustness of the culture, infection and image analysis
methodology (median %CV of 6.8% or less for these features).
(TIF)
Figure S7 Cumulative frequency distribution of the
effect of shRNAs on dendritic development in the
primary synapse screen. The dendrite outgrowth module of
our synapse analysis algorithm identified an enrichment of
hairpins reducing dendrite development in the library of 623
shRNAs targeting mouse genes (MsGenes) compared to the 80
negative control non-targeting shRNAs (p= 0.0348, 2 tailed t-test).
(TIF)
Figure S8 Absence of correlation between dendrite
development and density of individual synaptic punctae.
Primary screen analysis of the effect of 597 mouse shRNAs
(shMsGenes) and 20 positive control shRNAs and 80 negative
control hairpins (shNegCtrl) show little correlation between the
effect of shRNAs on dendrite development and the density of (A)
Psd95 (R2 of 0.3296 and 0.4226 for shMsGenes and shNegCtrl,
respectively), (B) Syn1 (R2 of 0.1038 and 0.2327 for shMsGenes
and shNegCtrl, respectively) and (C) Gphn (R2 of 0.2361 and
0.3971 for shMsGenes and shNegCtrl, respectively) punctae. The
symbols present the median results of replicate shRNA infection.
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The median absolute deviation was plotted for the positive control
shRNAs to Psd95, Syn1, Gphn and Tsc1.
(TIF)
Figure S9 Cumulative frequency distribution of the
effect of shRNAs on the development of excitatory and
inhibitory synapses. The cumulative frequency distribution of
the primary screen highlights the specificity of shPsd95, shGphn,
shSyn1 and shTsc1 on the development of Psd95-Syn1 excitatory
(A) and Gphn-Syn1 inhibitory punctae. (B) Shown are averaged
effects of 5 positive control shRNA targeting Psd95, Gphn, Syn1
and Tsc1 in comparison with 80 individual negative control
shRNA and 597 shRNAs targeting the mouse gene library.
(TIF)
Figure S10 Identification by image analysis and west-
ern blot of Axin1 as regulator of synapse development.
(A) The effect of all 5 shRNA reagents targeting Axin1 on synapse
development and dendrite outgrowth was quantified using the
synapse imaging algorithm (*p-values,0.05 or less (2-tailed t-tests,
see table S2)) (B) shRNAs also reduce synaptic protein expression
(mean and SD of primary screen results only) and (C) development
of excitatory and inhibitory synapses. (D) shRNAs that reduced
synapse development also reduced expression of Axin1 in DIV14
cortical mouse neuronal cultures confirming the on-target
specificity of these RNAi. (A) and (D) present median and median
absolute deviations of the primary screen and two secondary
screens. Statistical analysis is presented in Table S2 and S3.
(TIF)
Figure S11 Identification by image analysis and west-
ern blot of Grin2C as regulator of synapse development.
(A) The effect of all 5 shRNA reagents targeting Grin2C on
synapse development and dendrite outgrowth was quantified using
the synapse imaging algorithm (*p-values ,0.05 or less (2-tailed t-
tests, see table S2)) (B) shRNAs also reduce synaptic protein
expression (mean and SD of primary screen results only) and (C)
development of excitatory and inhibitory synapses. (D) shRNAs
that reduced synapse development also reduced expression of
Axin1 in DIV14 cortical mouse neuronal cultures confirming the
on-target specificity of these RNAi. (A) and (D) present median
and median absolute deviations of the primary screen and two
secondary screens. Statistical analysis is presented in Table S2 and
S3.
(TIF)
Figure S12 Effect on synapse development of shRNAs
targeting Axin2. (A) The effect of all 5 shRNA reagents
targeting Axin2 on synapse development and dendrite outgrowth
was quantified using the synapse imaging algorithm (*p-values ,
0.05 or less (2-tailed t-tests, see table S2)) (B) shRNAs also reduce
synaptic protein expression (mean and SD of primary screen
results only) and (C) development of excitatory and inhibitory
synapses. Data present the average data of the primary RNAi
screen. Statistical analysis is presented in Table S2 and S3.
(TIF)
Figure S13 Regulation of spine density by shRNAs
targeting Psd95 and Tsc1. Orthologous spine density assays
experiments confirm that shRNA to Psd95 #80 and Tsc1 #49
reduce spine density qualitatively (A) and quantitatively (B) p,
0.0001 (2-tailed T-test compared to GFP expressing vector) Scale
bar denotes 10 mm.
(TIF)
Table S1 Content of the shRNA lentiviral library. The
library consists of 607 shRNA targeting mouse genes (shMsGenes),
a negative control library of 80 unique non-targeting shRNA
(shGFP, shRFP, shLuc, shLac) and a set of 10 negative control
shRNAs infected as a pool in secondary synapse screens and for
western blot experiments.
(XLSX)
Table S2 T-test (2-tailed) of the effect of positive control
shRNA on synapse development in comparison to
negative control hairpins. This demonstrates statistically
significant changes (p-values in density of Psd95, Gphn, Syn1,
Psd95-Syn1 and Gphn-Syn1 punctae, and dendrite length, by
positive control shRNAs (shPSD95, shGphn, shSyn1, shTsc1) and
shRNAs targeting Axin1, Grin2C and Axin2.
(XLSX)
Table S3 Analysis, by one way ANOVA with Bonferro-
ni’s multiple comparisons correction, of the effects of
positive control shRNAs on synapse development of the
opposing class. This examines statistical significance of the
specificity of RNAi mediated knockdown on the density of the
intended target (in comparison with the other 2 synaptic punctae).
That is, shPsd95 preferentially suppresses Psd95 punctae, shGphn
targets Gphn punctae and shSyn1 targets Syn1 punctae. No
statistically significant difference was observed for the effect of
shTsc1 or shGrin2C on Psd95, Gphn and Syn1 density. In
contrast, 2 shRNAs targeting Axin1 significantly suppress the
density of post synaptic-excitatory Psd95 punctae density com-
pared to post synaptic-inhibitory Gphn punctae and pre-synaptic
Syn1 punctae.
(XLSX)
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